University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT04469049
This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and caregivers of people with PD.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94143, United States
An adapted MBCT intervention will be offered to people with Parkinson's disease (PD) and mild-to-moderate depression and/or anxiety, as well as caregivers of people with PD. Several 8-week long MBCT groups will be held between September 2020 and May 2021, based on the adapted protocol. The MBCT intervention will consist of 90-minute weekly groups focused on teaching mindfulness techniques and ways to recognize cognitive patterns that can increase anxiety and/or depression. Participants will be recruited from the community, according to the eligibility criteria detailed below. For all participants, the pre- and post-MBCT anxiety and/or depressive symptom severity and mindfulness levels (as measured with standardized, validated scales) will be compared, using a paired t-test. For caregivers, pre- and post-MBCT caregiver burden scores will be compared as well.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MBCT is an evidence-based psychotherapy which combines mindfulness skills with cognitive therapy strategies.
Time frame: From pre- to post-MBCT 8 weeks later
Change in Generalized Anxiety Disorder-7 item score (for participants with anxiety). The scale score range is 0-21, with higher scores indicating more severe anxiety.
Time frame: From pre- to post-MBCT 8 weeks later
Change in Patient Health Questionnaire-9 score (for participants with depression). The scale score range is 0-27, with higher scores indicating more severe depression.
Time frame: From pre- to post-MBCT 8 weeks later
Change in 15 item-Five Facet Mindfulness Questionnaire score. The scale score range is 0-75, with higher scores indicating higher mindfulness levels.
Time frame: From pre- to post-MBCT 8 weeks later
Change in AMA Caregiver Self-Assessment Questionnaire score. The scale score range is 0-16, with higher scores indicating higher caregiver burden.
University of California, San Francisco
Other
Mindfulness-based Cognitive Therapy for People With Parkinson's Disease and Caregivers
Acronym: MBCT-PD-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05335850
Anxiety, Anxiety Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT04932434
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial DetailsNCT03904654
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial DetailsNCT01323699
Anxiety, Anxiety Disorders
Houston, Texas, United States
View Trial Details